Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

RTTNews | 985 dni temu
Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

(RTTNews) - Biopharmaceutical company Xeris Biopharma Holdings, Inc. (XERS) announced Wednesday that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (HZNP).

Under the terms of the agreement, Xeris will use its proprietary formulation technology platform, XeriJect, to develop an ultra-concentrated, ready-to-use, subcutaneous injection of teprotumumab and Horizon will have an option to license the Xeris technology.

Teprotumumab is the first and only medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Thyroid Eye Disease (TED) - a serious, progressive and potentially vision-threatening rare autoimmune disease. Teprotumumab-trbw is known as TEPEZZA in the United States.

Xeris will receive an upfront payment, and may be entitled to receive development milestones, regulatory milestones, and sales-based milestones, as well as royalties based on future sales if the commercial license option is exercised. However, specific financial terms of the agreement were not disclosed.

For More Such Health News, visit rttnews.com

read more
Indian Rupee Falls To 4-day Low Against U.S. Dollar

Indian Rupee Falls To 4-day Low Against U.S. Dollar

The Indian rupee weakened against the U.S. dollar in the European session on Monday, as investors await the announcement of the interest rate decision by the Reserve Bank of India (RBI) on Wednesday.
RTTNews | 5 minut temu
CAC Moderately Higher As Stocks Recover From Recent Setback

CAC Moderately Higher As Stocks Recover From Recent Setback

The French stock market is up firmly in positive territory on Monday with several counters from across various sectors attracting buyers after last week's decline following a sweeping tariff announcement from U.S. President Donald Trump.
RTTNews | 11 minut temu
DAX Up 1.1% As Stocks Rebound From Recent Losses

DAX Up 1.1% As Stocks Rebound From Recent Losses

German stocks are up firmly in positive territory on Monday, recovering well from recent losses, as investors look past last week's tariff announcement from U.S. President Donald Trump and focusing on recent earnings.
RTTNews | 29 minut temu